• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类黏液样脂肪肉瘤中CHOP与一种新型RNA结合蛋白的融合。

Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.

作者信息

Crozat A, Aman P, Mandahl N, Ron D

机构信息

Department of Medicine, NYU Medical Center, New York 10016.

出版信息

Nature. 1993 Jun 17;363(6430):640-4. doi: 10.1038/363640a0.

DOI:10.1038/363640a0
PMID:8510758
Abstract

Human myxoid liposarcomas contain a characteristic chromosomal translocation, t(12;16)(q13;p11), that is associated with a structural rearrangement of the gene encoding CHOP, a growth arrest and DNA-damage inducible member of the C/EBP family of transcription factors residing on 12q13.1. Using a CHOP-specific complementary probe and antiserum we report here the presence of an abnormal CHOP transcript and protein in these tumours. Cloning of the translocation-associated CHOP gene product revealed a fusion between CHOP and a gene provisionally named TLS (translocated in liposarcoma). TLS is a novel nuclear RNA-binding protein with extensive sequence similarity to EWS, the product of a gene commonly translocated in Ewing's sarcoma. In TLS-CHOP the RNA-binding domain of TLS is replaced by the DNA-binding and leucine zipper dimerization domain of CHOP. Targeting of a conserved effector domain of RNA-binding proteins to DNA may play a role in tumour formation.

摘要

人类黏液样脂肪肉瘤含有一种特征性的染色体易位,即t(12;16)(q13;p11),它与编码CHOP的基因的结构重排相关,CHOP是一种生长停滞和DNA损伤诱导因子,属于位于12q13.1的C/EBP转录因子家族成员。我们在此使用CHOP特异性互补探针和抗血清报告这些肿瘤中存在异常的CHOP转录本和蛋白质。对易位相关的CHOP基因产物进行克隆,发现CHOP与一个暂命名为TLS(在脂肪肉瘤中易位)的基因发生了融合。TLS是一种新型的核RNA结合蛋白,与EWS具有广泛的序列相似性,EWS是一种在尤因肉瘤中常见的易位基因的产物。在TLS-CHOP中,TLS的RNA结合结构域被CHOP的DNA结合和亮氨酸拉链二聚化结构域所取代。将RNA结合蛋白的保守效应结构域靶向DNA可能在肿瘤形成中起作用。

相似文献

1
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.在人类黏液样脂肪肉瘤中CHOP与一种新型RNA结合蛋白的融合。
Nature. 1993 Jun 17;363(6430):640-4. doi: 10.1038/363640a0.
2
Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.嵌合型 TLS/FUS-CHOP 基因表达及其在人黏液样和圆形细胞脂肪肉瘤中连接区的异质性
Am J Pathol. 1995 Nov;147(5):1221-7.
3
Fusion of the EWS and CHOP genes in myxoid liposarcoma.黏液样脂肪肉瘤中EWS和CHOP基因的融合
Oncogene. 1996 Feb 1;12(3):489-94.
4
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.在恶性脂肪肉瘤中,通过12号和16号染色体易位(t(12;16)),显性负性转录调节因子CHOP与新基因FUS发生融合。
Nat Genet. 1993 Jun;4(2):175-80. doi: 10.1038/ng0693-175.
5
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.多灶性黏液样脂肪肉瘤的单克隆性:通过分析 TLS-CHOP 或 EWS-CHOP 重排进行确认。
Clin Cancer Res. 2000 Jul;6(7):2788-93.
6
FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.脂肪肉瘤组织中的FUS/TLS-CHOP嵌合转录本
Jpn J Clin Oncol. 1995 Dec;25(6):234-9.
7
TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.人髓系白血病中t(16;21)染色体易位产生的TLS/FUS-erg嵌合蛋白的TLS/FUS融合结构域具有转录激活结构域的功能。
Oncogene. 1994 Dec;9(12):3717-29.
8
Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.脂肪肉瘤中TLS-CHOP易位的基因组断点特征表明,转位蛋白和拓扑异构酶II参与了易位过程。
Oncogene. 1999 Jan 21;18(3):721-9. doi: 10.1038/sj.onc.1202364.
9
Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.黏液样脂肪肉瘤和急性髓性白血病中融合基因FUS/CHOP、EWS/CHOP和FUS/ERG断点处的特征性序列基序。
Oncogene. 1997 Sep;15(11):1357-62. doi: 10.1038/sj.onc.1201281.
10
RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.在人黏液样脂肪肉瘤细胞中,TLS/CHOP抑制由YB-1介导的RNA剪接。
J Orthop Res. 2002 Jul;20(4):723-9. doi: 10.1016/S0736-0266(02)00006-2.

引用本文的文献

1
Histomorphological and molecular characteristics of liposarcoma (Review).脂肪肉瘤的组织形态学和分子特征(综述)
Oncol Lett. 2025 Jul 21;30(4):454. doi: 10.3892/ol.2025.15200. eCollection 2025 Oct.
2
Intratumoral heterogeneity of cancer driver genomic alterations in myxoid liposarcomas.黏液样脂肪肉瘤中癌症驱动基因改变的肿瘤内异质性
Cancer. 2025 Jun 15;131(12):e35937. doi: 10.1002/cncr.35937.
3
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights.肌萎缩侧索硬化症和额颞叶痴呆中的RNA结合蛋白:从致病机制到治疗见解
Mol Neurodegener. 2025 Jun 4;20(1):64. doi: 10.1186/s13024-025-00851-y.
4
Collective unstructured interactions drive chromatin binding of transcription factors.集体性的无组织相互作用驱动转录因子与染色质的结合。
bioRxiv. 2025 May 23:2025.05.16.654615. doi: 10.1101/2025.05.16.654615.
5
Establishment and characterization of NCC-MLPS4-C1: a novel patient-derived cell line of myxoid liposarcoma.NCC-MLPS4-C1的建立与鉴定:一种新的黏液样脂肪肉瘤患者来源细胞系
Hum Cell. 2025 May 26;38(4):109. doi: 10.1007/s13577-025-01241-8.
6
Dynamic properties of transcriptional condensates modulate CRISPRa-mediated gene activation.转录凝聚物的动态特性调节CRISPRa介导的基因激活。
Nat Commun. 2025 Feb 14;16(1):1640. doi: 10.1038/s41467-025-56735-8.
7
The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications.剪接异构体与环状 RNA 在癌症中的相互作用:发病机制见解和治疗意义。
Cell Mol Biol Lett. 2024 Nov 16;29(1):142. doi: 10.1186/s11658-024-00662-x.
8
FUS::DDIT3 Fusion Protein in the Development of Myxoid Liposarcoma and Possible Implications for Therapy.FUS::DDIT3 融合蛋白在黏液样脂肪肉瘤的发生发展中的作用及其对治疗的可能影响。
Biomolecules. 2024 Oct 14;14(10):1297. doi: 10.3390/biom14101297.
9
Diagnosis and Treatment of Myxoid Liposarcoma.黏液样脂肪肉瘤的诊断与治疗。
Curr Treat Options Oncol. 2024 Oct;25(10):1289-1296. doi: 10.1007/s11864-024-01262-9. Epub 2024 Sep 20.
10
Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的发病机制和治疗学研究进展。
Cells. 2024 May 21;13(11):888. doi: 10.3390/cells13110888.